Items where authors include "Newton-Bishop, J"

Export as [feed] Atom [feed] RSS
Number of items: 32.

Article

Clarke, EL, Wade, RG, Magee, D et al. (2 more authors) (2023) Image analysis of cutaneous melanoma histology: a systematic review and meta-analysis. Scientific Reports, 13. 4774. ISSN 2045-2322

Birkeälv, S, Harland, M, Matsuyama, LSAS et al. (15 more authors) (2023) Mutually exclusive genetic interactions and gene essentiality shape the genomic landscape of primary melanoma. Journal of Pathology, 259 (1). pp. 56-68. ISSN 0022-3417

Kato, S, Weng, QY, Insco, ML et al. (20 more authors) (2020) Gain-of-Function Genetic Alterations of G9a Drive Oncogenesis. Cancer Discovery, 10 (7). pp. 980-997. ISSN 2159-8274

Vuong, K, Armstrong, BK, Drummond, M et al. (12 more authors) (2020) Development and external validation study of a melanoma risk prediction model incorporating clinically assessed naevi and solar lentigines. The British Journal of Dermatology, 182 (5). pp. 1262-1268. ISSN 0007-0963

Juraleviciute, M, Pozniak, J, Nsengimana, J et al. (11 more authors) (2020) MX 2 is a novel regulator of cell cycle in melanoma cells. Pigment Cell & Melanoma Research, 33 (3). pp. 446-457. ISSN 1755-1471

Hardie, CM, Elliott, F, Chan, M et al. (3 more authors) (2020) Environmental exposures such as smoking and low vitamin D are predictive of poor outcome in cutaneous melanoma rather than other deprivation measures. Journal of Investigative Dermatology, 140 (2). pp. 327-337. ISSN 0022-202X

Muralidhar, S, Filia, A, Nsengimana, J et al. (11 more authors) (2019) Vitamin D-VDR signaling inhibits Wnt/beta-catenin-mediated melanoma progression and promotes anti-tumor immunity. Cancer Research, 79 (23). pp. 5986-5998. ISSN 0008-5472

Thakur, R, Laye, JP, Lauss, M et al. (14 more authors) (2019) Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma. Clinical Cancer Research, 25 (24). pp. 7424-7435. ISSN 1078-0432

Poźniak, J, Nsengimana, J, Laye, JP et al. (15 more authors) (2019) Genetic and Environmental Determinants of Immune Response to Cutaneous Melanoma. Cancer Research, 79 (10). pp. 2684-2696. ISSN 0008-5472

Váraljai, R, Wistuba-Hamprecht, K, Seremet, T et al. (18 more authors) (2019) Application of circulating cell-free tumor DNA profiles for therapeutic monitoring and outcome prediction in genetically heterogeneous metastatic melanoma. JCO Precision Oncology. ISSN 2473-4284

Lipplaa, A, Fernandes, R, Marshall, A et al. (7 more authors) (2018) 25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial. British Journal of Cancer, 119 (7). pp. 793-800. ISSN 0007-0920

Lindsay, CR, Shaw, EC, Blackhall, F et al. (26 more authors) (2018) Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme. Esmo Open, 3 (6). e000408. ISSN 2059-7029

Tagliabue, E, Gandini, S, Bellocco, R et al. (15 more authors) (2018) MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled-analysis from the M-SKIP project. Cancer Management and Research, 10. pp. 1143-1154. ISSN 1179-1322

Nsengimana, J, Laye, J, Filia, A et al. (15 more authors) (2018) β-catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomas. Journal of Clinical Investigation, 128 (5). pp. 2048-2063. ISSN 0021-9738

Muinonen-Martin, AJ, O'Shea, SJ and Newton-Bishop, J orcid.org/0000-0001-9147-6802 (2018) Easily missed? Amelanotic melanoma. BMJ: British Medical Journal, 360 (8145). k826. ISSN 0959-8138

Del Castillo Velasco-Herrera, M, Van der Weyden, L, Nsengimana, J et al. (6 more authors) (2018) Comparative genomics reveals that loss of lunatic fringe (LFNG) promotes melanoma metastasis. Molecular Oncology, 12 (2). pp. 239-255. ISSN 1574-7891

Metri, R, Mohan, A, Nsengimana, J et al. (5 more authors) (2017) Identification of a gene signature for discriminating metastatic from primary melanoma using a molecular interaction network approach. Scientific Reports, 7. 17314. ISSN 2045-2322

Dinnes, J, Saleh, D, Newton-Bishop, J orcid.org/0000-0001-9147-6802 et al. (11 more authors) (2017) Tests to assist in the staging of cutaneous melanoma: a generic protocol. Cochrane Database of Systematic Reviews, 2017 (9). CD012806. ISSN 1465-1858

Jouenne, F, Chauvot de Beauchene, I, Bollaert, E et al. (33 more authors) (2017) Germline CDKN2A/P16INK4A mutations contribute to genetic determinism of sarcoma. Journal of Medical Genetics, 54 (9). pp. 607-612. ISSN 0022-2593

O'Shea, SJ orcid.org/0000-0002-1588-6022, Robles-Espinoza, C, McLellan, L et al. (10 more authors) (2017) A population-based analysis of germline BAP1 mutations in melanoma. Human Molecular Genetics, 26 (4). pp. 717-728. ISSN 0964-6906

O'Shea, SJ, Merchant, W, Laye, J et al. (5 more authors) (2017) Transcriptomic profiling the microenvironment in primary melanoma. Pigment Cell and Melanoma Research, 30 (1). p. 127. ISSN 1755-148X

Puig-Butille, JA, Gimenez-Xavier, P, Visconti, A et al. (10 more authors) (2017) Genomic expression differences between cutaneous cells from red hair colour individuals and black hair colour individuals based on bioinformatic analysis. Oncotarget, 8 (7). pp. 11589-11599. ISSN 1949-2553

Lauss, M, Nsengimana, J, Staaf, J et al. (2 more authors) (2016) Consensus of melanoma gene expression subtypes converges on biological entities. Journal of Investigative Dermatology, 136 (12). pp. 2502-2505. ISSN 0022-202X

Lubbe, SJ, Escott-Price, V, Brice, A et al. (16 more authors) (2016) Rare variants analysis of cutaneous malignant melanoma genes in Parkinson’s disease. Neurobiology of Aging, 48. 222.e1-222.e7. ISSN 0197-4580

Rogers, Z, Elliott, F, Kasparian, NA et al. (3 more authors) (2016) Psychosocial, clinical and demographic features related to worry in patients with melanoma. Melanoma Research, 26 (5). pp. 497-504. ISSN 0960-8931

Tagliabue, E, Gandini, S, García-Borrón, J et al. (23 more authors) (2016) Association of Melanocortin-1 Receptor Variants with Pigmentary Traits in Humans: A Pooled Analysis from the M-Skip Project. Journal of Investigative Dermatology, 136 (9). pp. 1914-1917. ISSN 0022-202X

Pal, A, Potjer, TP, Thomsen, SK et al. (12 more authors) (2016) Loss-of-Function Mutations in the Cell-Cycle Control Gene CDKN2A Impact on Glucose Homeostasis in Humans. Diabetes, 65 (2). pp. 527-533. ISSN 0012-1797

Tagliabue, E, Fargnoli, MC, Gandini, S et al. (20 more authors) (2015) MC1R gene variants and non-melanoma skin cancer: a pooled-analysis from the M-SKIP project. British Journal of Cancer, 113 (2). pp. 354-363. ISSN 0007-0920

Davies, JR, Chang, Y, Bishop, DT et al. (29 more authors) (2015) Development and Validation of a Melanoma Risk Score Based on Pooled Data from 16 Case-Control Studies. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 24 (5). 817 - 824. ISSN 1055-9965

Nsengimana, J, Laye, J, Filia, A et al. (10 more authors) (2015) Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort. Oncotarget, 6 (13). 11683 - 11693.

Abbotts, R, Jewell, R, Nsengimana, J et al. (13 more authors) (2014) Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy. Oncotarget, 5 (10). pp. 3273-3286. ISSN 1949-2553

Proceedings Paper

Hayes, AJ, Maynard, L, A'Hern, R et al. (7 more authors) (2015) Long term follow up of survival in a randomised trial of wide or narrow excision margins in high risk primary melanoma. In: Journal of Clinical Oncology. Annual Meeting of the American-Society-of-Clinical-Oncology, 29 May - 02 Jun 2015, Chicago, IL, USA. American Society of Clinical Oncology .

This list was generated on Sun Mar 24 10:40:12 2024 GMT.